Acumen Pharmaceuticals, Inc. (ABOS)
Nasdaq: ABOS · Biological Products, (No Diagnostic Substances) · Newton, MA · filing with the SEC since 2013
Who runs Acumen Pharmaceuticals, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Oconnell Daniel Joseph
Chief Executive Officer. First filing Jun 2021, latest Jan 23, 2026, 6 filings in all.
Officers reporting now
7
of 19 people with a filing in the last fifteen months
Directors reporting now
12
20 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Meisner Derek M | Chief Legal Officer & Corp Sec | Sep 2022 | Mar 10, 2026 | 16 · $200,000 |
| Oconnell Daniel Joseph | Chief Executive Officer | Jun 2021 | Jan 23, 2026 | 8 · $200,000 |
| Zuga Matt | CFO & Chief Business Officer | Jun 2021 | Jan 23, 2026 | 7 · $0.00 |
| Barton Russell | Chief Operating Officer | Jun 2021 | Jan 23, 2026 | 6 · $0.00 |
| Siemers Eric | Chief Medical Officer | Jun 2021 | Jan 23, 2026 | 4 · $0.00 |
| Doherty James J. | President and CDO | Feb 2024 | Jan 21, 2026 | 2 · $0.00 |
| Schacterle Amy | Chief Regulatory Officer | Nov 2024 | Jan 21, 2026 | 1 · $0.00 |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Porter Derrell | director | Jan 2023 | Jun 17, 2026 | 3 · $100,000 |
| Fountain Nathan B | director | Jun 2021 | Jun 10, 2026 | 1 · $0.00 |
| Drapkin Kimberlee C | director | Apr 2022 | Jun 5, 2026 | none |
| Golumbeski George | director | Nov 2025 | Jun 5, 2026 | none |
| Ives Jeffrey L. | director | Jun 2021 | Jun 5, 2026 | none |
| Kolchinsky Peter | director | Jun 2021 | Jun 5, 2026 | none |
| Ra Capital Healthcare Fund LP | director | Jun 2021 | Jun 5, 2026 | none |
| Ra Capital Management, L.P. | director | Jun 2021 | Jun 5, 2026 | none |
| Ra Capital Nexus Fund II, L.P. | director | Jun 2021 | Jun 5, 2026 | none |
| Shah Rajeev M. | director | Jun 2021 | Jun 5, 2026 | none |
| Stalfort John A III | director | Jun 2021 | Jun 5, 2026 | none |
| Stoppel Laura | director | Jun 2021 | Jun 5, 2026 | none |
Earlier names on the record7, newest filing first
Sevigny Jeffrey · director · last filing Jun 2022Hardie Robert D. · 10% owner · last filing Jul 2021Manning Paul B · 10% owner · last filing Jul 2021Sands Capital Global Venture Fund II, L.P. · 10% owner · last filing Jul 2021Sands Capital Life Sciences Pulse Fund, LLC · 10% owner · last filing Jul 2021Sands Capital Ventures Discovery Fund III, L.P. · 10% owner · last filing Jul 2021Sands Frank M. · 10% owner · last filing Jul 2021
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.